Key Changes
The following key changes can be noted with the revised announcement:
- INTEGRATED biomarker and imaging studies within a phase 2 treatment trial are now eligible for BIQSFP funding (Learn more about eligible studies).
- The funding mechanism for approved BIQSFP studies is via NCI Administrative Supplements (Learn more about the Mechanism of Support).
- Additional BIQSFP eligibility definitions have been added (View definitions).
- Additional detail has been added regarding integrated biomarker/imaging costs eligible for BIQSFP funding (Learn more about eligible costs).
- Additional informational resources have been added regarding validation of integral biomarkers (View resources).
Download Complete 2012 Announcement
(View 2011 Announcement)
(View 2010 Announcement)
